1. Comment on 'Testing for BRAF fusions in patients with advanced BRAF/NRAS/KIT wild-type melanomas permits to identify patients who could benefit of anti-MEK targeted therapy'. Issue 8 (18th December 2019) Authors: Botton, Thomas; Passeron, Thierry; Rocchi, Stéphane Journal: Journal of clinical pathology Issue: Volume 73:Issue 8(2020) Page Start: 524 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗